PDK-1 inhibitor (PHusis Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePDK-1 inhibitor (PHusis Therapeutics)
Drug Alias Name3-Phosphoinositide-dependent kinase 1 inhibitor (PHusis Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3-phosphoinositide-dependent protein kinase 1 inhibitors
Targets3-phosphoinositide-dependent protein kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPHusis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPHusis Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A